23andMe Privacy Reviewer’s Law Firm Discloses Work for Regeneron
WilmerHale said it’s representing the law professor tapped to make privacy-related recommendations about the sale of 23andMe’s customers’ genetic data while separately working for a major bidder for the assets, Regeneron Pharmaceuticals Inc., on unrelated matters.